This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Thomas Rupp, Managing Director at Axolabs, and Chris Rombach, Senior Vice President at Asahi Kasei Bioprocess discuss the future of oligonucleotide therapeutics and the challenges associated with large-scale manufacturing while at TIDES 2023 in San Diego, California.
